OrbusNeich Medical Group Holdings Limited (FRA:Q8T)

FRA:Q8T Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	168.74	164.1	153.87	136.82	116.46	88.47
Revenue Growth (YoY)	11.48%	6.65%	12.46%	17.48%	31.64%	-8.17%
Cost of Revenue	54.15	49.63	47.37	44.37	35.29	30.45
Gross Profit	114.59	114.47	106.5	92.46	81.17	58.02
Selling, General & Admin	62.94	62.7	54.84	55.13	50.06	41.11
Research & Development	17.72	17.05	14.38	14.11	12.15	12.46
Other Operating Expenses	-0.19	-0.44	-2.14	-0.92	-1.4	-2.4
Operating Expenses	80.83	79.65	67.14	68.57	60.7	50.24
Operating Income	33.76	34.82	39.36	23.89	20.48	7.78
Interest Expense	-0.2	-0.22	-0.13	-1.46	-5.61	-1.4
Interest & Investment Income	10.58	11.92	10.67	2.39	0.01	0.01
Earnings From Equity Investments	-1.65	-1.51	-0.84	-0.2	-0.21	-0.05
Currency Exchange Gain (Loss)	1.54	-0.71	-0.36	-0.97	-0.9	1.02
Other Non Operating Income (Expenses)	-0	-0	-0.01	-0.01	-0	-0
EBT Excluding Unusual Items	44.02	44.3	48.69	23.65	13.77	7.36
Impairment of Goodwill	-1.57	-1.57	-	-	-	-
Gain (Loss) on Sale of Investments	-0.52	-0.28	0.98	-1.49	-0.05	-0.11
Gain (Loss) on Sale of Assets	-0.01	-0.01	-0.05	-0.03	-0.08	0.01
Asset Writedown	-	-	-	-0.34	-	-
Other Unusual Items	-0.03	-0.03	0.01	0	-14.96	-
Pretax Income	41.9	42.41	49.63	21.79	-1.32	7.26
Income Tax Expense	1.08	2.56	4.56	3.3	3.13	0.18
Earnings From Continuing Operations	40.82	39.85	45.07	18.49	-4.44	7.07
Minority Interest in Earnings	-0.15	-0.13	-	-	-	-
Net Income	40.67	39.72	45.07	18.49	-4.44	7.07
Net Income to Common	40.67	39.72	45.07	18.49	-4.44	7.07
Net Income Growth	5.05%	-11.88%	143.76%	-	-	1.62%
Shares Outstanding (Basic)	824	826	828	583	577	577
Shares Outstanding (Diluted)	825	826	833	776	577	577
Shares Change (YoY)	-0.64%	-0.80%	7.29%	34.58%	-	-
EPS (Basic)	0.05	0.05	0.05	0.03	-0.01	0.01
EPS (Diluted)	0.05	0.05	0.05	0.03	-0.01	0.01
EPS Growth	5.75%	-11.09%	111.85%	-	-	2.13%
Free Cash Flow	-1.6	3.32	17.43	20.53	19.25	11.72
Free Cash Flow Per Share	-0.00	0.00	0.02	0.03	0.03	0.02
Dividend Per Share	0.013	0.013	0.013	-	-	-
Gross Margin	67.91%	69.76%	69.22%	67.57%	69.70%	65.58%
Operating Margin	20.01%	21.22%	25.58%	17.46%	17.58%	8.80%
Profit Margin	24.10%	24.20%	29.29%	13.51%	-3.82%	7.99%
Free Cash Flow Margin	-0.95%	2.02%	11.33%	15.01%	16.53%	13.25%
EBITDA	36.78	37.61	41.3	25.84	22.86	10.3
EBITDA Margin	21.80%	22.92%	26.84%	18.89%	19.63%	11.64%
D&A For EBITDA	3.02	2.79	1.94	1.95	2.39	2.52
EBIT	33.76	34.82	39.36	23.89	20.48	7.78
EBIT Margin	20.01%	21.22%	25.58%	17.46%	17.58%	8.80%
Effective Tax Rate	2.57%	6.04%	9.18%	15.14%	-	2.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.